Regenerative Joint Pain Treatment in Tokyo
Advanced orthopedic treatments using PRP and Stem Cell therapy to help reduce joint pain,
improve mobility, and support natural healing.
Advanced orthopedic treatments using PRP and Stem Cell therapy to help reduce joint pain,
improve mobility, and support natural healing.
Intra-articular injection is a minimally invasive orthopedic procedure in which therapeutic substances are injected directly into a joint. This approach allows targeted treatment of joint pain and inflammation while supporting joint function and mobility.
Depending on the patient’s condition and clinical assessment, regenerative options such as PRP (Platelet-Rich Plasma) or Stem Cell therapy may be recommended.
PRP (Platelet-Rich Plasma) therapy uses a concentrated portion of the patient’s own blood that is rich in growth factors. These growth factors may help reduce inflammation and support the body’s natural healing response within the joint.
Stem Cell therapy involves the use of regenerative cells that may support tissue and cartilage repair and joint regeneration. This treatment may be considered for patients with more advanced joint degeneration or chronic joint pain.
Intra-articular injections may be considered for a variety of joint-related conditions,
depending on the patient’s symptoms and clinical assessment.
The treatment process varies depending on the selected therapy and the patient’s clinical assessment.
The physician carefully listens to the patient’s concerns and evaluates their condition. Treatment goals, safety considerations, and expected outcomes are explained.
After informed consent, a small amount of the patient’s blood is collected.
The collected blood is processed using a centrifuge to concentrate platelets.
Platelet-Rich Plasma (PRP) is isolated for therapeutic use.
PRP is injected into the affected joint under medical supervision.
The physician evaluates the patient’s symptoms, medical history, and diagnostic findings. The role of stem cell therapy, treatment process, safety considerations, and eligibility criteria are explained in detail.
After informed consent, regenerative cells are obtained using an appropriate and approved method, as determined by the physician.
The collected cells are processed under controlled conditions to prepare them for therapeutic use.
The physician determines the appropriate treatment site, dosage, and approach based on the patient’s condition.
Prepared regenerative cells are administered to the affected joint or targeted area under clinical supervision.
